Tonix Pharmaceuticals Holding Corp. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

SUBSEQUENT EVENT (Details Narrative)

SUBSEQUENT EVENT (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands							3 Months Ended	12 Months Ended
	Dec. 31, 2017	Apr. 13, 2017	Apr. 04, 2017	Mar. 30, 2017	Mar. 17, 2017	Mar. 01, 2017	Apr. 30, 2017	Dec. 31, 2016	Dec. 31, 2015
Number of shares granted options to purchase								69,800	51,324
Exercise price (in dollars price per share)								$ 46.58	$ 60.13
Exercisable, weighted average remaining contractual term								7 years 2 months 8 days
Reverse stock split								1-for-10
Common stock, par value (in dollars per share)								$ 0.001	$ 0.001
Common stock, outstanding								(3,918,111)	(1,883,167)
Common stock, authorized								15,000,000	15,000,000
Proceeds from issuance of shares								$ 20,498	$ 47,685
Subsequent Event [Member]
Reverse stock split					1-for-10
Common stock, par value (in dollars per share)					$ 0.001
Common stock, outstanding					41,010,720
Number of shares sold					4,101,072		1,486,474
Common stock, authorized					15,000,000
Proceeds from issuance of shares							$ 9,100
Commission on issuance of shares							$ 300
Subsequent Event [Member] \| Underwriting Agreement [Member] \| Underwritten Public Offering [Member]
Proceeds from issuance of shares			$ 7,200
Commission on issuance of shares			$ 600
Sale of stock price per share			$ 0.31
Discount on purchase of shares			7.00%
Offering expenses			$ 300
Subsequent Event [Member] \| Underwriting Agreement [Member] \| 45 Days Over-Allotment Option [Member]
Number of shares sold		270,000
Proceeds from issuance of shares		$ 1,100
Commission on issuance of shares		$ 100
Sale of stock price per share		$ 0.31
Subsequent Event [Member] \| Underwriting Agreement [Member] \| Aegis Capital Corp. [Member] \| Underwritten Public Offering [Member]
Number of shares sold				1,800,000
Sale of stock price per share				$ 4.45
Subsequent Event [Member] \| Underwriting Agreement [Member] \| Aegis Capital Corp. [Member] \| 45 Days Over-Allotment Option [Member]
Number of shares sold				270,000
Subsequent Event [Member] \| Employee [Member]
Number of shares granted options to purchase	28,250					61,750
Exercise price (in dollars price per share)	$ 5.50					$ 5.50
Exercisable, weighted average remaining contractual term	10 years					10 years
Description of vesting terms						Vesting 1/3 on the first anniversary and 1/36th each month thereafter for 24 months.
Subsequent Event [Member] \| Employee [Member] \| Minimum [Member]
Vesting period	1 year